• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

社区药房的药学服务:来自世界各地的实践与研究。

Pharmaceutical care in community pharmacies: practice and research from around the world.

作者信息

Farris Karen B, Fernandez-Llimos Fernando, Benrimoj S I Charlie

出版信息

Ann Pharmacother. 2005 Sep;39(9):1539-41. doi: 10.1345/aph.1G049. Epub 2005 Jul 12.

DOI:10.1345/aph.1G049
PMID:16014373
Abstract

Pharmaceutical care models and practices differ in various countries. Reimbursement for cognitive services, for example, varies across countries in Europe, Asia, and the Americas. Practice-based research has blossomed in many countries, with different emphases and challenges. This international series will describe the organization of community pharmacy within the healthcare system and report the status of practice-based research. Each paper will focus on one country. The series will conclude with a summary by the series editors describing the key themes across the papers, outlining milestones yet to be achieved, and proposing a research agenda for community pharmacy practice.

摘要

不同国家的药学服务模式和实践存在差异。例如,认知服务的报销情况在欧洲、亚洲和美洲各国各不相同。基于实践的研究在许多国家蓬勃发展,侧重点和面临的挑战也各不相同。这个国际系列将描述社区药房在医疗保健系统中的组织情况,并报告基于实践的研究现状。每篇论文将聚焦于一个国家。该系列将由系列编辑进行总结,描述各篇论文的关键主题,概述尚未实现的里程碑,并提出社区药房实践的研究议程。

相似文献

1
Pharmaceutical care in community pharmacies: practice and research from around the world.社区药房的药学服务:来自世界各地的实践与研究。
Ann Pharmacother. 2005 Sep;39(9):1539-41. doi: 10.1345/aph.1G049. Epub 2005 Jul 12.
2
Pharmaceutical care in community pharmacies: practice and research in Sweden.社区药房的药学服务:瑞典的实践与研究
Ann Pharmacother. 2006 Jun;40(6):1162-9. doi: 10.1345/aph.1G680. Epub 2006 May 30.
3
Pharmaceutical care in community pharmacies: practice and research in Switzerland.瑞士社区药房的药学服务:实践与研究
Ann Pharmacother. 2006 Mar;40(3):512-7. doi: 10.1345/aph.1G199. Epub 2006 Feb 7.
4
Pharmaceutical care in community pharmacies: practice and research in the US.社区药房的药学服务:美国的实践与研究
Ann Pharmacother. 2006 Jul-Aug;40(7-8):1400-6. doi: 10.1345/aph.1G545.
5
Current state of community pharmacy in Japan: practice, research, and future opportunities or challenges.日本社区药房的现状:实践、研究及未来机遇或挑战。
Ann Pharmacother. 2006 Nov;40(11):2008-14. doi: 10.1345/aph.1H221. Epub 2006 Oct 24.
6
Pharmaceutical care in community pharmacies: practice and research in Estonia.爱沙尼亚社区药房的药学服务:实践与研究
Ann Pharmacother. 2008 Jul;42(7):1104-11. doi: 10.1345/aph.1K644. Epub 2008 Jun 24.
7
Pharmaceutical care in community pharmacies: practice and research in Canada.社区药房的药学服务:加拿大的实践与研究
Ann Pharmacother. 2005 Sep;39(9):1527-33. doi: 10.1345/aph.1E456. Epub 2005 Jul 12.
8
Pharmaceutical care in community pharmacies: practice and research in Germany.德国社区药房的药学服务:实践与研究
Ann Pharmacother. 2006 Apr;40(4):729-35. doi: 10.1345/aph.1G458. Epub 2006 Mar 28.
9
The effects of managed care on the retail distribution of pharmaceuticals.管理式医疗对药品零售分销的影响。
Manag Care Interface. 1998 Nov;11(11):105-8, 111-3.
10
Pharmaceutical care in community pharmacies: practice and research in Brazil.巴西社区药房的药学服务:实践与研究
Ann Pharmacother. 2007 Sep;41(9):1486-93. doi: 10.1345/aph.1K080. Epub 2007 Jul 31.

引用本文的文献

1
Australian pharmacists' experiences and perspectives in implementing a chronic kidney disease screening service in community pharmacies: A qualitative study.澳大利亚药剂师在社区药房开展慢性肾脏病筛查服务的经验与观点:一项定性研究。
Explor Res Clin Soc Pharm. 2025 Aug 21;20:100643. doi: 10.1016/j.rcsop.2025.100643. eCollection 2025 Dec.
2
Improving Clinical Pharmacist Performance in Oncology Care Through Education on Pharmaceutical Care Plans Documentation: A Pre-post Interventional Study.通过药物治疗计划记录教育提高临床药师在肿瘤护理中的表现:一项前后对照干预性研究。
Inquiry. 2025 Jan-Dec;62:469580251335819. doi: 10.1177/00469580251335819. Epub 2025 May 14.
3
Feasibility and Impact of Community Pharmacy and Novel Pick-up Points for Antiretroviral Therapy Pre-exposure Prophylaxis Initiation and Continuation in Low and Middle-income Countries.
社区药房和新型取药点在中低收入国家开展艾滋病病毒暴露前预防治疗启动和持续治疗的可行性和影响。
Curr HIV/AIDS Rep. 2024 Nov 16;22(1):2. doi: 10.1007/s11904-024-00710-3.
4
Barriers to pharmaceutical care provision in the community and hospital pharmacies of Motta town, Northwest Ethiopia: a cross-sectional study.在埃塞俄比亚西北部莫塔镇的社区和医院药房中提供药物治疗的障碍:一项横断面研究。
BMC Health Serv Res. 2024 Sep 17;24(1):1082. doi: 10.1186/s12913-024-11538-3.
5
Development and validation of an assessment tool for public perceptions toward drive-thru community pharmacy services in Malaysia during COVID-19.开发和验证马来西亚在 COVID-19 期间公众对免下车社区药房服务看法的评估工具。
Front Public Health. 2023 Aug 3;11:1144466. doi: 10.3389/fpubh.2023.1144466. eCollection 2023.
6
Evaluation of pharmaceutical care services in the Middle East Countries: a review of studies of 2013-2020.评价中东国家的药学服务:2013-2020 年研究综述。
BMC Public Health. 2023 Jul 17;23(1):1364. doi: 10.1186/s12889-023-16199-1.
7
Type 2 Diabetes Patients' Views of Local Pharmacists and Fulfilment with Pharmaceutical Diabetes Care in Syria's Latakia Governorate: An Online Survey Research.叙利亚拉塔基亚省2型糖尿病患者对当地药剂师的看法及对糖尿病药物治疗的满意度:一项在线调查研究
Healthcare (Basel). 2023 Jun 12;11(12):1720. doi: 10.3390/healthcare11121720.
8
Association of pharmaceutical care barriers and role ambiguity and role conflict of clinical pharmacists.药学服务障碍与临床药师角色模糊及角色冲突的关联
Front Pharmacol. 2023 May 9;14:1103255. doi: 10.3389/fphar.2023.1103255. eCollection 2023.
9
Outcomes of Pharmacist-Led Pharmaceutical Care Interventions Within Community Pharmacies: Narrative Review.社区药房中由药剂师主导的药学服务干预的结果:叙述性综述
Integr Pharm Res Pract. 2023 May 15;12:113-126. doi: 10.2147/IPRP.S408340. eCollection 2023.
10
Attitudes, awareness, and perceptions of general public and pharmacists toward the extended community pharmacy services and drive-thru pharmacy services: a systematic review.普通公众和药剂师对社区药房扩展服务及得来速药房服务的态度、认知和看法:一项系统综述
J Pharm Policy Pract. 2023 Mar 2;16(1):37. doi: 10.1186/s40545-023-00525-4.